Digital Poster Exhibition
65th Annual Meeting Society of Thrombosis and Hemostasis Research

 


A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study


A. Merrelaar
Medical University Vienna

Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip


A. Merrelaar
Medical University Vienna

Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland


S. Naas
Inselspital, Bern University Hospital, Maastricht University

A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A


M. E. Mancuso
Humanitas Clinical and Research Center - IRCCS

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone


A. Abendroth
University Hospital Duesseldorf

A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII


S. Bonanad
University and Polytechnic La Fe Hospital

Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease


L. Papageorgiou
Sorbonne University, Tenon University Hospital

An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database


C. Negrier
Louis Pradel University Hospital, University Claude Bernard

Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication


R. Fischer
Haemophilia Center SHR Kurpfalz, University Hospital Heidelberg

A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)


M. Binder
University Hospital Halle

A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain


M. E. Mancuso
Humanitas Clinical and Research Center - IRCCS

Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells


R. Djedidi - Amrane
Diagnostica Stago, Institut National de la Santé et de la Recherche Médicale (INSERM)

Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF


M. Höpting
University Hospital Regensburg

Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.


M. Reschke
Universitiy Hospital Essen, University medicine Charité

Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder


J. Goldstein
Loyola University Medical Center

Characterization of rFIX fusion proteins enabling subcutaneous administration


K. Schön
CSL Behring GmbH

Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader


N. Buchtele
Medical University Vienna

Comparing automated FXIII assays


M. Leitner
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH

Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice


E. Janus-Bell
Strasbourg University, INSERM, EFS Grand Est, BPPS UMR-S1255, FMTS

Detection thrombogenicity antiphospolipid antibodies with APC modified TGT


L. Slavík
Faculty of Medicine and Dentistry, Palacky University Olomouc; University Hospital Olomouc, University Hospital and Faculty of Medicine and Dentistry, Palacký University Olomouc

Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication


W. Mondorf
Haemostas-Frankfurt

Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.


A. Nemani
University Heart Center Freiburg – Bad Krozingen

Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk


M. G. Zermatten
Lausanne University Hospital

Evaluation of different processing methods to label platelets for in vivo studies


C. Muret
Transfusion Interrégionale CRS

Evaluation of thrombin generation in patients with sickle cell disease in stable disease and sickle cell crises


I. Hegemann
University Hospital Zurich

Evolution of platelet phenotype during SARS-CoV-2 infection


D. Mege
Aix Marseille Univ, INSERM, INRAe

Examination of the Rac-modulator ArhGAP15 in platelet activation.


A. Margraf
University Hospital Münster

Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia


J. Machacek
Medical University Vienna

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients


G. Fontana
University of Trieste

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis


P. Saultier
Aix Marseille Univ, INSERM, INRAe

Hepatic Disorders Contribute to Platelet Dysfunction


C. Bacher
Loyola University Medical Center

Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports


S. Margetić
Sestre milosrdnice University Hospital Center

Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency


D. Mehic
Medical University Vienna

Insight into the role of miR-223-3p in regulating platelet reactivity


A. Garcia
University of Geneva

Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test


S. Hetjens
Medical Faculty Mannheim University of Heidelberg

International Myeloma Working Group ( IMWG) score accuracy in multiple myeloma patients: need for action.


L. Papageorgiou
Sorbonne University, Tenon University Hospital

In vitro characterization of K5A and K5R variants of Factor IX


S. Knoll Machado
CSL Behring GmbH

Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication


K. Holstein
University Medical Center Hamburg-Eppendorf

Laboratory phenotype variability in genetically proven von Willebrand disease type 2B


S. Marten
University Hospital Dresden

Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen


I. Pabinger
Medical University Vienna

Monitoring pain and joint health in patients with haemophilia


N. Granzow
Vivantes Hospital im Friedrichshain

Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research


C. Bidlingmaier
Dr. von Haunerschen Kinderspital

Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?


P. Bradacova
Masaryk Hospital

Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome


N. Hagedorn
University medicine Charité

Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System


S. Bockel
Ulm University Hospital

Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer


S. Thouroude
Centre de Recherche Saint-Antoine (CRSA), Institut National de la Santé et de la Recherche Médicale (INSERM)

Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.


W. Jeske
Loyola University Chicago, Loyola University Medical Center

Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany


J. Oldenburg
University Hospital Bonn

Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets


I. Krueger
University Hospital Duesseldorf

Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation


T. Flieder
Heart and Diabetes Center North Rhine-Westphalia

Reversal of DOAC in RVV-test on the ClotPro analyzer


T. Lang
Gerinnungszentrum GerinnungONE

Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.


A. Kouta
Loyola University Chicago, Loyola University Medical Center

smart medication DocuScan: GSAV-compliant documentation of hemophilia preparations for pharmacies, doctors, treatment centers and patients


A. Roesch
smart medication eHealth Solutions GmbH

Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.


B. Dharavath
Loyola University Medical Center

The occurrence of trombocythopathy in CLL patients treated with Ibrutinib


K. Chasakova
Hospital in Havirov

The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation


T. Feige
University Hospital Duesseldorf

Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment


H.-J. Hertfelder
University Hospital Bonn

Thrombopoietin levels in sepsis and septic shock - a meta-analysis.


A. Margraf
University Hospital Münster

Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab


L. Völker
Cologne Cluster of Excellence on Cellular Stress Responses in Ageing Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne

Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia


D. Kranzhöfer
University Medical Center Freiburg

Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy


D. Bertaggia Calderara
Lausanne University Hospital

Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate


B. Dharavath
Loyola University Medical Center
Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.